| 标题 |
Amivantamab plus chemotherapy vs. chemotherapy as first-line treatment in Chinese mainland patients with EGFR exon 20 insertion non-small cell lung cancer: Subgroup analysis of the randomized PAPILLON trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:Chinese Medical Journal 作者:Kejing Tang; Fengying Wu; Fang Yang; Yu Yao; Yanqiu Zhao; et al 出版日期:2026 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)